Nasdaq triple IPO play brings in $345M as the big biotech party rocks on
After Entasis Therapeutics $ETTX hit the floor on Nasdaq Wednesday after pricing its offering below the range, the stock cratered fast, plunging 29% and likely …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.